DK0443413T3 - Farmaceutisk præparat med afpigmenterende virkning og antifotoældningsvirkning - Google Patents

Farmaceutisk præparat med afpigmenterende virkning og antifotoældningsvirkning

Info

Publication number
DK0443413T3
DK0443413T3 DK91101930.5T DK91101930T DK0443413T3 DK 0443413 T3 DK0443413 T3 DK 0443413T3 DK 91101930 T DK91101930 T DK 91101930T DK 0443413 T3 DK0443413 T3 DK 0443413T3
Authority
DK
Denmark
Prior art keywords
combination
effect
azelaic
pigmenting
retinoic
Prior art date
Application number
DK91101930.5T
Other languages
English (en)
Inventor
Ruggero Caputo
Original Assignee
Schering Spa
Cilag Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Spa, Cilag Spa filed Critical Schering Spa
Application granted granted Critical
Publication of DK0443413T3 publication Critical patent/DK0443413T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
DK91101930.5T 1990-02-20 1991-02-12 Farmaceutisk præparat med afpigmenterende virkning og antifotoældningsvirkning DK0443413T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT01942290A IT1242478B (it) 1990-02-20 1990-02-20 Composizioni farmaceutiche ad attivita' depigmentante e contro il danneggiamento cutaneo fotoindotto.

Publications (1)

Publication Number Publication Date
DK0443413T3 true DK0443413T3 (da) 1994-07-25

Family

ID=11157744

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91101930.5T DK0443413T3 (da) 1990-02-20 1991-02-12 Farmaceutisk præparat med afpigmenterende virkning og antifotoældningsvirkning

Country Status (14)

Country Link
EP (1) EP0443413B1 (da)
JP (1) JPH08239320A (da)
KR (1) KR910021235A (da)
AT (1) ATE104144T1 (da)
AU (1) AU7118091A (da)
CA (1) CA2036678A1 (da)
DE (1) DE69101651T2 (da)
DK (1) DK0443413T3 (da)
IE (1) IE910558A1 (da)
IL (1) IL97271A0 (da)
IT (1) IT1242478B (da)
NZ (1) NZ237137A (da)
PT (1) PT96814B (da)
ZA (1) ZA911222B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547989A (en) * 1994-08-19 1996-08-20 Schering-Plough Healthcare Products, Inc. Compositions for treating corns and calluses
US20050226899A1 (en) * 2004-04-08 2005-10-13 Mauro Castiglioni Cosmetic mask composition
DE102006004804A1 (de) 2006-01-23 2007-07-26 Intendis Gmbh Verwendung von Alkandicarbonsäuren und Retinoiden zur Behandlung entzündlicher Hauterkrankungen
US20100273756A1 (en) * 2009-04-27 2010-10-28 Reza Babapour Adjunctive formulation and methods for palliation of fine wrinkles, mottled hyperpigmentation, tactile roughness of facial skin and related disorders
PH12013500784A1 (en) 2010-10-21 2019-07-17 Cadila Healthcare Ltd Pharmaceutical compositions comprising nano size droplets of skin whitening agents
US10064884B2 (en) 2015-07-30 2018-09-04 Curology, Inc. Composition and methods of treating acne and photoaging
CA3106323A1 (en) 2018-07-30 2020-02-06 Curology, Inc. Compositions and methods of treating acne and photoaging

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877805A (en) * 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
DE3623862A1 (de) * 1986-07-11 1988-01-21 Schering Ag Verwendung von dicarbonsaeuren mit 7 - 13 kohlenstoffatomen oder physiologisch vertraeglichen salzen davon zur topischen behandlung von rosazea
JP2565513B2 (ja) * 1987-09-25 1996-12-18 三省製薬株式会社 メラニン生成抑制外用薬剤

Also Published As

Publication number Publication date
IE910558A1 (en) 1991-08-28
IT1242478B (it) 1994-03-17
AU7118091A (en) 1991-08-22
EP0443413B1 (en) 1994-04-13
NZ237137A (en) 1992-04-28
ATE104144T1 (de) 1994-04-15
IT9019422A1 (it) 1991-08-21
JPH08239320A (ja) 1996-09-17
PT96814B (pt) 1998-07-31
IT9019422A0 (it) 1990-02-20
ZA911222B (en) 1991-11-27
KR910021235A (ko) 1991-12-20
IL97271A0 (en) 1992-05-25
DE69101651D1 (de) 1994-05-19
CA2036678A1 (en) 1991-08-21
PT96814A (pt) 1991-10-31
EP0443413A1 (en) 1991-08-28
DE69101651T2 (de) 1994-08-11

Similar Documents

Publication Publication Date Title
ATE89723T1 (de) Retinoide zur behandlung lichtgeschaedigter haut.
DE69004817D1 (de) Zusammensetzung und Verfahren zur Behandlung von Erkrankungen.
DE69003652D1 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen.
EP0053448A3 (en) Pre-shampoo type hair treatment composition
ATE145136T1 (de) Verwendung von ketoconazol und ein retinoid zur behandlung der akne vulgaris
DE69033040D1 (de) Verfahren zur Herstellung von biologisch aktivem Protein (z.B. TGF)
ATE126433T1 (de) Verwendung von gamma-hydroxy-buttersäuresalzen zur herstellung von pharmazeutischen zusammensetzungen zur verwendung bei der behandlung von alkoholismus und die hergestellten zusammensetzungen.
IT1105040B (it) 3-1h-tetrazol-5-il-4h-pirido 1,2-a pirimidin-4-oni sostituiti utili in particolare come agenti terapeutici per inibire le reazioni allergiche e procedimento per la produzione dei detti derivati
DE69218255D1 (de) Verwendung von amino-2-trifluormethoxy-6-benzothiazol (riluzol) zur herstellung eines medikamentes zur behandlung von erkrankungen des motoneurons
DE69004071D1 (de) Lagerstabile reisprodukte und verfahren zu ihrer herstellung.
DE59303365D1 (de) Derivate in der vitamin d-reihe mit modifikationen in der 20 position, verfahren zu ihrer herstellung, zwischenprodukte für dieses verfahren, diese derivate enthaltende pharmazeutische präparate sowie deren verwendung zur herstellung von arzneimitteln
FI103506B1 (fi) Menetelmä syklisten aminohappojohdannaisten valmistamiseksi ja menetelmässä käytettävä välituote
DE69628296D1 (de) Verwendung von sophorolipiden zur herstellung kosmetischer produkte, insbesondere zur behandlung der haut
ES2058680T3 (es) Citrato de l-carnitina y magnesio.
ATE114412T1 (de) Verwendung eines pyrodextrinhydrolysates zur herstellung einer nahrungsmittelzusammensetzung zur verbesserung der serumlipidzusammensetzung.
BR9402089A (pt) Composição para cuidado da pele e processo para melhorar as propriedades de irritação provocada por retinol
ATE274349T1 (de) Verwendung von fruktan zur herstellung eines arzneimittels zur vorbeugung und behandlung von dickdarmkrebs
DE68924714D1 (de) Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen.
CA2326148A1 (en) Method for providing glutamine
IL97271A0 (en) Pharmaceutical compositions having depigmentating and antiphotoageing activity
ATE98121T1 (de) Fettsaeuren zur behandlung und praevention von hautschaeden durch radiotherapie.
ATE102019T1 (de) Mittel zur kosmetischen oder pharmazeutischen verwendung.
ATE143809T1 (de) Placentaextrakt und verfahren zu seiner herstellung
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
DE69106451D1 (de) Zusammensetzung und verwendung dieser zusammensetzung zur herstellung eines arzneimittels für die behandlung von durch wärme- und lichtstrahlung verursachten verletzungen.